NovaBay Pharmaceuticals, Inc. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Jun 8, 2016
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
stock option (right to buy)
2016-06-06+675,000→ 698,248 totalExercise: $2.78From: 2017-01-31Exp: 2026-06-06→ Common Stock (675,000 underlying)
Footnotes (1)
- [F1]One-third (1/3) of the shares subject to the Option will vest on January 31, 2017, in direct proportion to the percentage achievement of the stated 2016 corporate goals, as approved and determined by the Board. The remaining two-thirds (2/3) of the shares subject to the Option shall vest in equal parts on January 31, 2018 and 2019, subject to the successful completion of certain performance criteria, to be determined by the Board in January of each year. Should the performance criteria be met, the Option will be fully vested and exercisable on January 31, 2019, subject to Mr. Sieczkarek continuing to be employed by the Company through the relevant vesting dates.